By reducing oxidative stress and enhancing mitochondrial efficiency, metformin lowers inflammation and insulin resistance, key contributors to galectin-3 overexpression (Zhang et al., 2021; Zhu et al., 2023; Kingwell, 2016). This evidence concerns the gene LGALS3 and Insulin resistance.